|
Symbol
|
YOTLTQ | LTHCLK | AAIETQ | AAXSTQ | RMA3QV | LJSULK | ABSFTQ | CQWBKB | LXWCLK | SKS6LK | QDPRCH | ADRATQ | LZQRCH | ADSXTQ | RMBU5V | AECRTQ | RMBFBV | AERWTQ | LHEHLK | RMBZJV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nom | Worst of Callable Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Reverse Convertible | Worst of Reverse Convertible | Multi Vonti | LUKB Multi Reverse Convertible | Worst of Reverse Convertible | Reverse Convertible | LUKB Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Reverse Convertible | Multi Vonti | Worst of Reverse Convertible | Multi Vonti | Multi Reverse Convertible | LUKB Softcallable Multi Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
Nestlé S.A. / Novartis AG / Roche PS | ABB / Nestlé S.A. / Novartis AG / Roche PS / Swiss RE AG | Nestlé S.A. / Novartis AG / Roche PS | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Alcon / Lonza Group N / Novartis AG / Roche PS / Sandoz Group AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Lonza Group N / Novartis AG / Roche PS / Straumann Hldg. AG | Nestlé S.A. / Novartis AG / Roche PS / Swisscom N | Galderma Group AG / Novartis AG / Sika AG | Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | ABB / Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG | Givaudan / Novartis AG / Sandoz Group AG | Nestlé S.A. / Novartis AG / Roche PS | Lonza Group N / Novartis AG / Straumann Hldg. AG / Ypsomed Hldg. AG | Compagnie Financière Richemont SA / Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | Kühne & Nagel Intl. AG / Novartis AG / Sika AG | Novartis AG / Roche PS / Sanofi S.A. | Nestlé S.A. / Novartis AG / Roche PS / Zurich Insurance Group AG | Nestlé S.A. / Novartis AG / Roche PS / UBS Group AG / Zurich Insurance Group AG |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
24.11.2027 | 09.07.2027 | 19.07.2027 | 13.09.2027 | 09.11.2026 | 19.11.2026 | 20.12.2027 | 13.03.2028 | 25.03.2027 | 07.04.2027 | 16.05.2028 | 04.08.2028 | 07.08.2029 | 11.08.2028 | 22.02.2027 | 25.09.2028 | 04.10.2027 | 01.12.2027 | 15.12.2028 | 20.12.2027 |
| Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
74,2425 | 58,7776 | 52,063 | 43,77 | 56,14 | 62,176 | 37,59 | 78,705 | 76,296 | 174,48 | 65,7375 | 35,72 | 2 627,25 | 46,384 | 292,70 | 281,20 | 130,88 | 60,487 | 58,7475 | 408,70 |
| rendement max. p.a. | 3,91% | 4,46% | 0,23% | 1,70% | -1,87% | -2,22% | 1,91% | 6,29% | 3,14% | 13,02% | 4,73% | 3,31% | 4,10% | 1,93% | 2,79% | 3,33% | 2,97% | 5,78% | 5,60% | 3,55% |
| Demande | 102,95 | - | 101,07 | 101,24 | - | - | 101,19 | 98,18 | - | - | 100,26 | 99,59 | 100,07 | 100,95 | 99,90 | 99,57 | 100,00 | 100,52 | - | 100,20 |
| Offre | 103,83 | - | 101,93 | 102,10 | - | - | 102,05 | 99,03 | - | - | 101,12 | 100,44 | 100,92 | 101,81 | 101,30 | 100,42 | 101,00 | 101,38 | - | 101,20 |